gastrimod | Akthelia Pharma

Akthelia News Desk

Oct 17

Akthelia Pharmaceuticals Awarded RANNIS Grant to Accelerate Development of Gastrimod® (AKT-011) for Chemotherapy-Induced FN

Akthelia Pharmaceuticals is pleased to announce it has been awarded a two-year $350,000 research grant by RANNIS

Akthelia News Desk

Sep 8

Akthelia Pharmaceuticals presents new translational mucosal barrier injury efficacy data at NLSD 2024

Akthelia Pharma will present exciting new translational data, and partnering and capital raising objectives at Nordic Life Science Days 2024

SUBSCRIBE TO RECEIVE OUR NEWS